Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | TBPH | BVS | ||
| Company | Ars Pharmaceuticals Inc | Theravance Bio Ord | Bioventus Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.03 | 15.40 | 9.09 | ||
| High | 8.24 | 16.28 | 9.38 | ||
| Low | 7.81 | 15.38 | 8.64 | ||
| Latest | 8.03 | 16.23 | 9.13 | ||
| Change | +0.21 | +0.97 | +0.17 | ||
| % Change | +2.75% | +6.36% | +1.90% | ||
| Volume | 1,850,400 | 816,200 | 582,000 | ||
| 20-Day Average Volume | 1,685,565 | 792,315 | 505,090 | ||
| Previous Close | 7.82 | 15.26 | 8.96 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.40 | 14.35 | 8.88 | ||
| 20-Day Raw Stochastic | 33.86% | 98.35% | 71.83% | ||
| 20-Day Relative Strength | 42.40 | 50.93 | 57.17 | ||
| Weighted Alpha | -45.56 | +82.29 | +23.22 | ||
| Today's Opinion | 100% Sell | 24% Sell | 100% Buy | ||
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.50% since 03/24/26 | +8.93% since 03/24/26 | -0.22% since 03/24/26 | ||
| Low | 7.61 on 03/27/26 | 14.70 on 03/30/26 | 8.64 on 03/31/26 | ||
| High | 8.70 on 03/26/26 | 16.28 on 03/31/26 | 9.39 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -13.47% since 02/27/26 | -11.07% since 02/27/26 | +3.99% since 02/27/26 | ||
| Low | 7.20 on 03/24/26 | 13.08 on 03/03/26 | 8.11 on 03/09/26 | ||
| High | 9.65 on 03/10/26 | 19.37 on 03/02/26 | 9.53 on 03/05/26 | ||
| 3-Month | |||||
| %Chg | -29.44% since 12/26/25 | -13.85% since 12/26/25 | +22.39% since 12/26/25 | ||
| Low | 7.20 on 03/24/26 | 13.08 on 03/03/26 | 7.14 on 01/02/26 | ||
| High | 13.15 on 01/12/26 | 21.03 on 01/22/26 | 9.53 on 03/05/26 | ||
| 6-Month | |||||
| %Chg | -18.06% since 09/26/25 | +15.35% since 09/26/25 | +37.09% since 09/26/25 | ||
| Low | 6.66 on 11/21/25 | 13.08 on 03/03/26 | 6.37 on 10/10/25 | ||
| High | 13.15 on 01/12/26 | 21.03 on 01/22/26 | 9.53 on 03/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 797,355 | 835,731 | 759,205 | ||
| Shares Outstanding, K | 99,297 | 51,493 | 83,155 | ||
| Annual Sales | 84,280,000 | 107,460,000 | 568,090,000 | ||
| Annual Net Income | -171,300,000 | 105,900,000 | 22,730,000 | ||
| Last Quarter Sales | 28,090,000 | 45,890,000 | 157,900,000 | ||
| Last Quarter Net Income | -41,320,000 | 61,020,000 | 14,760,000 | ||
| 60-Month Beta | 0.78 | 0.17 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 03/09/26 | 0.06 on 03/19/26 | 0.24 on 03/05/26 | ||
| Latest Earnings Date | 05/13/26 | 05/14/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.35 | 13.18 | ||